BrainStorm Cell Therapeutics
BCLI
#10977
Rank
HK$70.97 M
Marketcap
HK$6.43
Share price
5.13%
Change (1 day)
19.98%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of June 2026 : HK$10.77 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is HK$10.77 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$1.61 M-71.05%
2024-12-31HK$5.58 M-43.87%
2023-12-31HK$9.95 M-68.86%
2022-12-31HK$31.97 M-19.25%
2021-12-31HK$39.6 M-29.21%
2020-12-31HK$55.94 M203.62%
2019-12-31HK$18.42 M
2018-12-31N/A
2010-12-31HK$1.06 M-62.84%
2009-12-31HK$2.86 M-16.2%
2008-12-31HK$3.42 M-71.51%
2007-12-31HK$12.01 M37.2%
2006-12-31HK$8.75 M
2006-03-31HK$3.86 M
2004-03-31HK$0.24 M47.42%
2003-03-31HK$0.16 M107.37%
2002-03-31HK$0.07 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Biogen
BIIB
HK$65.53 B 607,985.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$205.86 B 1,910,089.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
HK$0.89 B 8,159.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$9.96 B 92,371.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$0.31 B 2,862.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA